期刊文献+

糖尿病对PCI治疗预后的影响 被引量:2

Impact of diabetes mellitus on prognosis of PCI therapy
下载PDF
导出
摘要 目的 观察糖尿病(DM)患者接受经皮冠状动脉介入治疗(PCI)的预后情况,评价DM对冠心病介入治疗预后的影响。方法 回顾性分析2012年7月-2014年6月于辽宁省大石桥市中心医院心内科收治的行PCI术的583例患者的临床资料,按是否合并DM分为DM组152例和非糖尿病(NDM)组431例,记录两组患者术后1年内再次心肌梗死、PCI术,冠状动脉旁路移植术及死亡等主要不良心血管事件(MACE)发生情况。结果 DM组1年死亡率为4.6%,显著高于NDM组的0.7%(P〈0.01),DM组的再次心肌梗死率为12.5%,高于NDM组的6.3%(P〈0.01),DM组的总心血管不良事件发生率为25.7%,高于NDM组的13.9%(P〈0.01)。结论 冠心病合并DM患者接受PCI术后发生MACE的比例较高,因此,尽管患者成功接受了PCI治疗,仍需重视糖尿病的进一步治疗,持续关注血糖、血脂。 Objective To observe the prognosis situation of diabetic patients accepted percutaneous coronary intervention(PCI) and to evaluate the impact of diabetes mellitus on prognosis of PCI. Methods Data of 583 patients conducted PCI in department of cardiology in Dashiqiao Central Hospital of Liaolin Province from July 2012 to June 2014 were retrospectively analyzed.Patients were divided into DM group(n=152) and NDM(n=431) group by wether combined with diabetes mellitus or not.The main adverse cardiovascular events(MACE) incidence situation liked miocardial infarction and PCI operation again,coronary artery bypass surgery and death in after 1 year operation in two groups were recorded. Results 1 year mortality rate in DM group was 4.6%,and it was obviously higher than that of NDM group(0.7%)(P〈0.01).Miocardial infarction rate again was 12.5% in DM group,and it was higher than that of NDM group(6.3%)(P〈0.01).The incidence rate of total adverse cardiovascular event in DM group was 25.7%,and it was higher than that of NDM group(13.9%)(P〈0.01). Conclusion The ratio of coronary heart disease patients with diabetes mellitus occurred MACE after PCI is higher.So,although patients are given successfully underwent PCI therapy,it still needs to attach importance to the further treatment of diabetes,and continuous pay attention to blood sugar and blood fat.
作者 谢建伟
出处 《中国当代医药》 2016年第2期33-35,共3页 China Modern Medicine
关键词 PCI术 糖尿病 预后 不良事件 PCI operation Diabetes mellitus Prognosis Adverse event
  • 相关文献

参考文献15

  • 1Grundy SM,Benjamin IJ,Burke GL,et a/.Diabetes and car- diovascular disease :a statement for heahhcare profession- als from the American Heart Association [J].Circulation, 1999,100(10) : 1134-1146.
  • 2Garg P,Normand SL,Silbaugh TS,et a/.Drug--eluting or bare- metal stenting in patients with diabetes mellitus:results from the Massachusetts Data Analysis Center Registry[J]. Circulation, 2008,118 (22) : 2277-2285.
  • 3Haffner SM, Lehto S,Ronnemaa T,et a/ . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior my- ocardial infarction[J].N Engl J Med, 1998,339(4) :229-234.
  • 4Sprafka JM,Burke GL,Folsom AR,et a/.Trends in preva- lence of diabetes mellitus in patients with myocardial in- farction and effect of diabetes on survival: the Minnesota Heart Survey[J].Diabetes Care, 1991,14(7) :537-543.
  • 5陈康寅,李广平.冠心病合并糖尿病患者血运重建--CABG仍优于PCI——评CARDia研究1年随访结果[J].中国循证心血管医学杂志,2010,2(4):208-210. 被引量:6
  • 6Sun N,Wang H,Sun Y,et a/.Detecting diabetic risk using the oral glucose tolerance test in Chinese patients with hypertension: a cross-sectional study [J].Hypertens Res, 2014,37 (1) : 82-87.
  • 7Bartnik M, Malmberg K,Norhammar A,et a/.Newly detect- ed abnormal glucose tolerance:an important predictor of long-term outcome after myocardial infarction[J].Eur Heart J, 2004,25 (22) : 1990-1997.
  • 8刘闺男,周敬.糖尿病-冠心病等危症的新理念及新思考[J].实用糖尿病杂志,2005,1(2):7-9. 被引量:18
  • 9Mehran R,Dangas GD,Kobayashi Y,et a/.Short- and long- term results after muhivessel stenting in diabetic patients[J]. J Am Coll Cardiol,2004,43(8) :1348-1354.
  • 10Srikanth S,Deedwania P.Management of coronary artery disease in patients with type 2 diabetes mellitus[J].Curr Cardiol Rep, 2007,9 (4) : 264-27 I.

二级参考文献34

  • 1徐向进,潘长玉,田慧,陆菊明.糖代谢异常老年人群死亡率的分析[J].中华内分泌代谢杂志,2003,19(4):267-270. 被引量:36
  • 2Bainey KR,Norris CM,Graham MM,et al.Clinical in-stent restenoeis with bare metal stents:is it truly a benign phenomenon?Int J Cardiol,2008,128:378-382.
  • 3Suselbeck T,Latsch A,Siri H,et al.Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes meilitus.Am J Cardiol,2001,88:243-247.
  • 4Iijima R,Ndrepepa G,Mehilli J,et al.Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.Am Heart J,2007,154:688-693.
  • 5Nishio K,Sakurai M,Knsuyama T,et al.A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes.Diabetes Care,2006,29:101-106.
  • 6Mehran R,Dangas GD,Kobayashi Y,et al.Short-and long-term results after multivessel stenting in diabetic patients.J Am Coil Cardiol,2004,43:1348-1354.
  • 7Moustapha A,Assali AR,Sdringola S,et al.Percutancous and surgical interventions for in-stent restenosis:long-term outcomes and effect of diabetes mellitus.J Am Coil Cardiol,2001,37:1877-1882.
  • 8Cole JH,Jones EL,Craver JM,et al.Outcomes of repeat revascularization in diabetic patients with prior coronary surgery.J Am Coll Cardiol,2002,40:1968-1975.
  • 9Srikanth S,Deedwania P.Management of coronary artery disease in patients with type 2 diabetes mellitus.Curr Cardiol Rep,2007,9:264-271.
  • 10Flaherty JD,Davidson CJ.Diabetes and coronary revascularization.JAMA,2005,293:1501-1508.

共引文献34

同被引文献20

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部